Pegfilgrastim

  • Part D specialty tier in 79% of formularies (2026Q3)
  • Biologic
  • NYVEPRIA

Therapy management checklist

Screening, baseline and ongoing monitoring with the label's stated frequency, hold and discontinue criteria, and counseling points, each quoted from the FDA label.

Loading the therapy management checklist…

Storage and cold chain

Pegfilgrastim: storage and handling

Refrigerate
Yes, as the label states
Label statement
Store refrigerated at 2°C to 8°C (36°F to 46°F) in the original carton to protect from light.
Freezing
Do not freeze
Label statement
Avoid freezing; if frozen, thaw in the refrigerator before administration.
Room temperature
up to 15 days
Label statement
Discard syringes stored at room temperature for more than 15 days.
Room temperature
up to 15 days at or below 25°C (77°F)
Label statement
Throw away (dispose of) any NYVEPRIA that has been left at room temperature, 68°F to 77°F (20°C to 25°C), for more than 15 days.
Back into the refrigerator
Not addressed
Light
Protect from light
Label statement
Store refrigerated at 2°C to 8°C (36°F to 46°F) in the original carton to protect from light.
Shaking
Do not shake
Label statement
Do not shake.

Temperature excursion helper

Answers only from this label's storage statements. It does not judge whether a product is still usable beyond what the label states.

Within the label's stated room-temperature allowance (up to 15 days). Follow the label's instructions for what to do next.

Entered: 1 day at up to 77°F (25°C).

Discard syringes stored at room temperature for more than 15 days.
Discard syringe if frozen more than once.
Throw away (dispose of) any NYVEPRIA that has been left at room temperature, 68°F to 77°F (20°C to 25°C), for more than 15 days.

If anything else happened to the product, or you are unsure, Contact the manufacturer at 1-800-438-1985 (the number printed on the label) about this product.

Where the label prints this number
1974 Distributed by Pfizer Labs, division of Pfizer Inc., New York, NY 10001 USA For more information go to www.pfizer.com or call 1-800-438-1985.
All storage statements on the label (14)
  • Store refrigerated at 2°C to 8°C (36°F to 46°F) in the original carton to protect from light.
  • Discard syringes stored at room temperature for more than 15 days.
  • Avoid freezing; if frozen, thaw in the refrigerator before administration.
  • Discard syringe if frozen more than once.
  • Do not shake.
  • How should I store NYVEPRIA single-dose prefilled syringe? .
  • Store NYVEPRIA in the refrigerator between 36°F to 46°F (2°C to 8°C). .
  • Do not freeze.
  • If NYVEPRIA is accidentally frozen, allow the prefilled syringe to thaw in the refrigerator before injecting. .
  • Do not use a NYVEPRIA prefilled syringe that has been frozen more than 1 time.
  • Keep NYVEPRIA in the original carton to protect from light or physical damage. .
  • Do not shake NYVEPRIA. .
  • Take NYVEPRIA out of the refrigerator 30 minutes before use and allow it to reach room temperature, 68°F to 77°F (20°C to 25°C), before preparing an injection. .
  • Throw away (dispose of) any NYVEPRIA that has been left at room temperature, 68°F to 77°F (20°C to 25°C), for more than 15 days.

FDA label version 9, effective June 2, 2026. DailyMed

Dosing and titration calendar

Built only from the schedules the label states (loading, titration, day schedules, cycles and weight bands). Steps the label states in words the calendar cannot place are shown, not guessed.

Loading dosing schedules…

Biosimilars

Neulasta: 9 licensed biosimilar products, 0 interchangeable (FDA Purple Book). Compare presentations and dates

Medicare Part D coverage

81%of plans list it
93%of those: prior authorization
0%step therapy
41%quantity limit
96%specialty tier

5,496 Part D plans, CMS formulary files 2026Q3. Look up tier, PA, step therapy and quantity limits by plan

Patient assistance

No manufacturer program page is listed for this drug yet.

Independent foundations and the full directory (checked 2026-11-06). Eligibility and amounts are set by each program; open its page for them.

For licensed clinicians. Use with clinical judgment. Statements are quoted from the FDA label; confirm against the label for the product you are using.